Risk factor
Very poor trading liquidity
Profitability factor
Undervalued vs peers
About
Kukje Pharma Co., Ltd. operates as a comprehensive pharmaceutical company, handling the manufacturing, import, export, sales, and distribution of its extensive product range. Its offerings include both prescription (ETC) and over-the-counter (OTC) pharmaceutical drugs, alongside vital raw materials, intermediates, and side-chain compounds. The company also diversifies its portfolio with cosmetics and various health care products. Kukje Pharma's pharmaceutical catalog addresses numerous therapeutic areas, featuring antibiotics like cephalosporins, quinolones, tetracyclines, aminoglycosides, and macrolides. They also provide specialized agents for ophthalmic, antifungal, and antiviral conditions, adrenal corticosteroids, and medications for central nervous system (CNS) and osteoporotic issues. Furthermore, their product line encompasses antihistamines, NSAIDs and other analgesics, and drugs targeting gastrointestinal, cardiovascular, diabetic, genitourinary, and respiratory ailments, among other ethical (ETC) products. Established in 1959, the company's headquarters are located in Seongnam, South Korea.
Company Valuation
Considering past and projected metrics, the stock is 'cheaper' than its peers. In particular, the stock is underpriced on P/E, of fair value on EV/EBITD.